Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changchun Xiangtong Pharmaceutical is a Chinese pharmaceutical company based in Changchun, Jilin Province, specializing in the production of chemical drugs and traditional Chinese medicine (TCM). Established in 2003, the company focuses on manufacturing a variety of dosage forms, including tablets, capsules, and granules, with a strong emphasis on over-the-counter (OTC) respiratory treatments. Its core product portfolio includes widely used medications for the common cold, influenza, and pain relief, such as Compound Paracetamol and Amantadine Hydrochloride Capsules. The company operates modern manufacturing facilities that are fully compliant with national Good Manufacturing Practice (GMP) standards. Changchun Xiangtong Pharmaceutical primarily serves the domestic healthcare market in China and is recognized as a key regional player in the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changchun Xiangtong Pharmaceutical.